title: Imiquimod 3.75% in actinic keratosis: efficacy in patients with and without rest periods during treatment.
authors: Dermatological Practice Centre, Wuppertal, Germany.|Faculty of Health, University Witten-Herdecke, Witten, Germany.
authors: T
authors: T
authors: Dirschka
authors: Department of Dermatology, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy.
authors: K
authors: K
authors: Peris
authors: Department of Dermatology, Monklands Hospital, Airdrie, Lanarkshire, ML6 0JS, UK.
authors: G
authors: G
authors: Gupta
authors: Department of Dermatology, Institut Universitari Quiron Dexeus, Av. Carles III 71-75, 8028, Barcelona, Spain.
authors: A
authors: A
authors: Alomar
authors: Service de Dermatologie Allergologie, Hôpital Cochin, 89 rue d'Assas, 75006, Paris, France.|Université Paris 5 Descartes, Paris, France.
authors: S
authors: S
authors: Aractingi
authors: Meda Pharma GmbH & Co. KG, Benzstrasse 1, 61353, Bad Homburg, Germany.
authors: R
authors: R
authors: Dakovic
authors: Klinik für Dermatologie, Venerologie und Allergologie, St. Josef-Hospital, Ruhr-Universität Bochum, Bochum, Germany.
authors: E
authors: E
authors: Stockfleth
mesh_terms: D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D000077271:Imiquimod; D055623:Keratosis, Actinic / Q000188:drug therapy*
chemical_list: D000634:Aminoquinolines; D000077271:Imiquimod